Sanofi pulls leukemia drug ahead of possible OK for MS drug
23:35 EDT 20 Sep 2012 | Amsterdam Biomed Cluster
August 20, 2012 - Sanofi's rare disease unit Genzyme is pulling leukemia drug Campath to prepare for its launch under a different dosage and as a multiple sclerosis treatment that will be branded as Lemtrada.
Original Article: Sanofi pulls leukemia drug ahead of possible OK for MS drug
More From BioPortfolio on "Sanofi pulls leukemia drug ahead of possible OK for MS drug"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
